- Home
- OCUL vs REAL Comparison
OCUL vs REAL Comparison
Compare OCUL & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OCUL | REAL |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | OCUL | REAL |
|---|---|---|
| Price | $10.76 | $11.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 8 |
| Target Price | ★ $22.90 | $17.00 |
| AVG Volume (30 Days) | ★ 7.6M | 3.4M |
| Earning Date | 05-06-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.55 |
| EPS | N/A | ★ N/A |
| Revenue | $1,990,000.00 | ★ $692,845,000.00 |
| Revenue This Year | $9.35 | $12.55 |
| Revenue Next Year | $92.88 | $9.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 3.48 | ★ 15.38 |
| 52 Week Low | $6.23 | $4.61 |
| 52 Week High | $16.44 | $17.39 |
Technical Indicators
Market Signals| Indicator | OCUL | REAL |
|---|---|---|
| Relative Strength Index (RSI) | 59.29 | 39.31 |
| Support Level | $10.65 | $10.06 |
| Resistance Level | $12.63 | $12.84 |
| Average True Range (ATR) | 0.75 | 0.86 |
| MACD | 0.40 | 0.15 |
| Stochastic Oscillator | 85.67 | 29.53 |
Price Performance
Historical ComparisonAbout OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.